Loading institutional data...
Loading institutional data...
Held by 376 of 5,944 reporting institutions (96th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.94B 100.0% | $6.83B 100.0% | $5.97B 100.0% | $5.51B 100.0% | $5.28B 100.0% | $4.66B 100.0% | $4.51B 100.0% | $3.68B 100.0% | $3.38B 100.0% | $3.26B 100.0% |
| Cost of Revenue | $6.00B 75.6% | $5.19B 76.0% | $4.49B 75.2% | $4.14B 75.1% | $3.92B 74.3% | $3.50B 75.0% | $3.37B 74.8% | $2.71B 73.5% | $2.37B 70.3% | $2.29B 70.4% |
| Gross Profit | $1.94B 24.4% | $1.64B 24.0% | $1.48B 24.8% | $1.37B 24.9% | $1.36B 25.7% | $1.17B 25.0% | $1.14B 25.2% | $976.2M 26.5% | $1.00B 29.7% | $965.3M 29.6% |
| Research & Development | $599.6M 7.6% | $544.1M 8.0% | $502.7M 8.4% | $501.8M 9.1% | $447.9M 8.5% | $428.2M 9.2% | $368.7M 8.2% | $317.7M 8.6% | $301.4M 8.9% | $291.7M 8.9% |
| Selling, General & Admin | $347.3M 4.4% | $311.0M 4.6% | $330.3M 5.5% | $313.0M 5.7% | $267.4M 5.1% | $223.9M 4.8% | $214.7M 4.8% | $160.3M 4.4% | $133.3M 3.9% | $151.4M 4.6% |
| Total Operating Expenses | — | — | — | — | — | — | $814.9M 18.1% | $683.3M 18.6% | $678.6M 20.1% | $660.6M 20.3% |
| Operating Income | $671.4M 8.5% | $489.1M 7.2% | $369.1M 6.2% | $367.5M 6.7% | $418.5M 7.9% | $325.7M 7.0% | $321.6M 7.1% | $292.8M 7.9% | $324.4M 9.6% | $304.7M 9.3% |
| Interest Expense | $146.4M 1.8% | $157.8M 2.3% | $143.9M 2.4% | $54.4M 1.0% | $42.3M 0.8% | $74.4M 1.6% | $73.0M 1.6% | $46.5M 1.3% | $36.1M 1.1% | $25.2M 0.8% |
| Interest & Investment Income | — | — | — | — | $6.1M 0.1% | — | — | — | — | — |
| Other Income (Expense), net | -$138.6M -1.7% | -$151.1M -2.2% | -$137.8M -2.3% | -$51.4M -0.9% | -$40.4M -0.8% | -$71.3M -1.5% | -$69.1M -1.5% | -$44.1M -1.2% | -$34.5M -1.0% | -$23.7M -0.7% |
| Pretax Income | $561.9M 7.1% | $341.7M 5.0% | $226.5M 3.8% | $292.6M 5.3% | $383.5M 7.3% | $261.8M 5.6% | $246.3M 5.5% | $237.3M 6.4% | $284.8M 8.4% | $279.2M 8.6% |
| Income Tax Expense | $55.5M 0.7% | $39.1M 0.6% | $22.9M 0.4% | $24.1M 0.4% | $131.4M 2.5% | $36.4M 0.8% | $19.4M 0.4% | $26.4M 0.7% | $55.6M 1.6% | $45.6M 1.4% |
| Net Income | $534.3M 6.7% | $321.1M 4.7% | $215.1M 3.6% | $275.4M 5.0% | $274.4M 5.2% | $237.7M 5.1% | $227.9M 5.1% | $206.7M 5.6% | $239.1M 7.1% | $236.9M 7.3% |
| Per Share | ||||||||||
| EPS (Basic) | $11.69 | $7.22 | $4.85 | $6.21 | $6.21 | $5.38 | $5.20 | $4.83 | $5.59 | $5.54 |
| EPS (Diluted) | $11.39 | $7.18 | $4.82 | $6.18 | $6.20 | $5.38 | $5.20 | $4.83 | $5.59 | $5.54 |
| Weighted Avg Shares (Basic) | 45.7M | 44.5M | 44.4M | 44.3M | 44.2M | 44.2M | 43.8M | 42.8M | 42.8M | 42.7M |
| Weighted Avg Shares (Diluted) | 46.9M | 44.7M | 44.6M | 44.6M | 44.3M | 44.2M | 43.8M | 42.8M | 42.8M | 42.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $748.56 today, the market must believe free cash flow compounds 26.5%/yr for a decade (off $436M normalized FCF).
The market's 26.5% is more optimistic than its 9-yr track record.
2-stage DCF · 0.05B shares · net debt -$534M
mean -114.6% · volatility σ 169% · implied rate exceeded in 2/6 yrs
Central path = implied 26.5%/yr growth; shaded band = ±1σ (169%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 20% of free cash flow, leaving room to grow it and fund buybacks. Last year: $112M dividends + $0 buybacks = $112M returned on $553M FCF.
1 consecutive years of dividend increases · 5%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 13%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $635M covers all $400M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2011-12-31 (20-F/A).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~144.3% on $101M of debt.
Cash of $635M fully covers short-term debt of $83M.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 14-yr range · 100th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.3× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 73.5 | 74.8 | 75.0 | 74.3 | 75.1 | 75.2 | 76.0 | 75.6 |
| Gross Profit | 26.5 | 25.2 | 25.0 | 25.7 | 24.9 | 24.8 | 24.0 | 24.4 |
| R&D | 8.6 | 8.2 | 9.2 | 8.5 | 9.1 | 8.4 | 8.0 | 7.6 |
| SG&A | 4.4 | 4.8 | 4.8 | 5.1 | 5.7 | 5.5 | 4.6 | 4.4 |
| Operating Income | 7.9 | 7.1 | 7.0 | 7.9 | 6.7 | 6.2 | 7.2 | 8.5 |
| Income Tax | 0.7 | 0.4 | 0.8 | 2.5 | 0.4 | 0.4 | 0.6 | 0.7 |
| Net Income | 5.6 | 5.1 | 5.1 | 5.2 | 5.0 | 3.6 | 4.7 | 6.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ESLT: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $28.75T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $364.2B | 41.6× | 29.1× | 5.4× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.2B | 38.4× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $264.2B | 39.7× | 18.8× | 3.0× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $204.4B | 81.4× | 41.0× | 2.3× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $181.0B | 36.2× | — | 4.0× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $174.3B | 47.1× | 31.1× | 5.4× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $166.7B | 23.4× | 16.0× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $154.3B | 38.1× | — | 5.6× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.9B | 28.2× | 16.2× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.0B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $117.9B | 33.9× | 26.6× | 5.9× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.7B | 25.0× | — | 5.0× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $97.3B | 23.3× | 17.1× | 1.9× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.0B | 32.5× | 23.2× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| PWR | $92.6B | 91.1× | 46.0× | 3.3× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| VRT | $91.6B | 70.2× | 43.4× | 8.9× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| JCI | $91.6B | 27.9× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $91.5B | 61.4× | 40.3× | 11.1× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $86.2B | 27.1× | 16.6× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.2B | 31.9× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $83.9B | 15.1× | 9.4× | 0.9× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $82.1B | 36.1× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $80.4B | 45.3× | 28.9× | 7.8× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| ESLT | $34.3B | 64.8× | 40.0× | 4.3× | 16.3% | 24.4% | 6.7% | 12.9% | 12.6% | 0.1× | 376 |
Peers = companies sharing ESLT's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.